Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor über 4 Jahren |
| Titel | Datum |
|---|---|
| MISC sinks into red for the first time in more than two years as provisions hurt | vor ungefähr 4 Monaten |
|
The Recipient Copy Deadline for 1099-B, 1099-S, and 1099-MISC is Approaching Fast: TaxBandits Makes Distribution Easy
Businesses must meet the February 18, 2025 deadline to furnish recipient copies of Forms 1099-B, ... |
vor ungefähr 5 Monaten |
| SBM Offshore finalizes asset swap with MISC Berhad | vor ungefähr 5 Monaten |
| SBM Offshore and MISC wrap up FPSO stake swap | vor ungefähr 5 Monaten |
|
SBM Offshore N.V.: SBM Offshore completes the Share Purchase Agreements with MISC Berhad
Amsterdam, January 31, 2025 SBM Offshore confirms it has completed the transactions related to t... |
vor ungefähr 5 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |